Analysis of the tumor images, weights, and volumes revealed that the treatment efficacy significantly deteriorated with the use of the broad-spectrum caspase inhibitor Z-VAD, moderately decreased with the GSDME inhibitor, and did not significantly change with the other inhibitors (Fig. 2B, C, and D). Here, GSDME is linked to neoplasm.